| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/18/2008 | US20080226655 Kallikrein-Inhibitor Therapies |
| 09/18/2008 | US20080226654 Uses of mammalian cytokine; related reagents |
| 09/18/2008 | US20080226653 Inhibition of Platelet Aggregation |
| 09/18/2008 | US20080226652 Rabies virus G protein specific immunoglobulin for use in prevention and treatment viral infection |
| 09/18/2008 | US20080226651 Envelope protein specific immunoglobulin for use in treatment and prevention human immunodeficieny virus infection |
| 09/18/2008 | US20080226650 Cotinine neutralizing antibody |
| 09/18/2008 | US20080226649 Cytosine/guanine nucleotide sequences for use as therapeutic in treatment of allergy, asthma, cancer, infection, anemia, thrombocytopenia and neutropenia. |
| 09/18/2008 | US20080226648 Using cysteamine compound to treat immunological disorders |
| 09/18/2008 | US20080226647 Using interferon gamma receptor 1 (IFNGR1) specific immunoglobulin for diagnosis, prevention and treatment of myxovirus infection |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | US20080226645 Methods and compositions for assessment and treatment of asthma |
| 09/18/2008 | US20080226644 Nucleotide sequences coding breast cancer protein (BCMP 101) for use in developing vaccines and immunoglobulin which target and destroy tumor tissues; antitumor agents |
| 09/18/2008 | US20080226643 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/18/2008 | US20080226642 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226641 Mixture comprising group B streptococcal peptide for use in generating vaccine and immunoglobulins for diagnosis, prevention and treatment of urinary tract infections |
| 09/18/2008 | US20080226640 Mixture comprising serum complement system protein (INSP162) use in preparation of vaccines and antibodies for treatment and prevention of infcetion, cell proliferative, skin, neurodegenerative, bone, inflammatory, respiratory system and autoimmune disorders |
| 09/18/2008 | US20080226639 Heparin Binding Peptide |
| 09/18/2008 | US20080226638 Using suppressor of uncoupling protein-1(SOUP1) for use in treatment and prevention of obesity, eating and wasting disorders |
| 09/18/2008 | US20080226637 Hemophilus polypeptide for generating immunoglobulins and vaccines for use in prevention and treatment of bacterial infection |
| 09/18/2008 | US20080226636 Novel human ulip/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes |
| 09/18/2008 | US20080226635 Transmembrane receptor specific immunoglobulin for use in targeting and destroying pancreatic, lung and/or breast cancers |
| 09/18/2008 | US20080226634 Tes7 and antibodies that bind thereto |
| 09/18/2008 | US20080226633 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/18/2008 | US20080226632 Cell growth factor specific immunoglobulin for treatment and prevention of cell proliferative and skin disorders |
| 09/18/2008 | US20080226631 Methods of modulating cytokine activity; related reagents |
| 09/18/2008 | US20080226630 Recombinant antibodies for treatment of respiratory syncytial virus infections |
| 09/18/2008 | US20080226628 CDR-Grafted Anti-Tissue Factor Antibodies and Methods of Use Thereof |
| 09/18/2008 | US20080226627 Using clostridium botulinum neurotoxin complex (Hn-33) protein as diagnostic tool in identifying modulators for treatment and prevention of clostridial poisoning; antitumor agents |
| 09/18/2008 | US20080226626 Treating B cell malignancy via administering immunoglobulin specific for B7 polypeptides; antitumor therapy |
| 09/18/2008 | US20080226625 Stable non- aqueous single phase viscous vehicles and formulations utlizing such vehicles |
| 09/18/2008 | US20080226624 Combined treatment of cancer by urokinase inhibition and a cytostatic anti-cancer agent for enhancing the anti-metastatic effect |
| 09/18/2008 | US20080226623 Stabilized protein crystals, formulations comprising them and methods of making them |
| 09/18/2008 | US20080226622 Hypoxia inducible factor (Hif); for modulating mRNA translation within cells; prevents excessive vascularization |
| 09/18/2008 | US20080226620 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226619 Anti-Muc1 Alpha/Beta Antibodies |
| 09/18/2008 | US20080226618 Hydantoin derivatives useful as antibacterial agents |
| 09/18/2008 | US20080226607 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226606 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226598 Dendritc specific RNA viral plasmid comprising nucleotide sequences coding tumor associated for use in developing cancer vaccine; genetic vaccines |
| 09/18/2008 | US20080226594 Culturing circular ssdna viruses for the production of vaccines |
| 09/18/2008 | US20080226589 Compositions and methods of use of phorbol esters |
| 09/18/2008 | US20080226563 Non-invasive localization of a light-emitting conjugate in a mammal |
| 09/18/2008 | US20080226556 Using macrophages;milk fat globulins; epidermal growth factor mutants |
| 09/18/2008 | US20080226549 Diagnosing cancer; measuring antibody inhibition; calibration; reduced concentration of inhibitor indicates cancer receptivity |
| 09/18/2008 | DE102007012824A1 Vaccine strains with graded colony size/attenuation comprise at least two attenuating metabolic drift mutations that are resistance mutations |
| 09/18/2008 | CA2813040A1 Secreted campylobacter flagella coregulated proteins as immunogens |
| 09/18/2008 | CA2703136A1 Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer |
| 09/18/2008 | CA2688121A1 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts |
| 09/18/2008 | CA2683977A1 Virus like particle purification |
| 09/18/2008 | CA2680932A1 Treatment or prophylaxis of asthma |
| 09/18/2008 | CA2680914A1 Monoclonal human tumor-specific antibody |
| 09/18/2008 | CA2680792A1 Treatment of autoimmune disorders |
| 09/18/2008 | CA2680280A1 Remedy for chemotherapy-resistant cancer containing hla class i-recognizing antibody as the active ingredient and use of the same |
| 09/18/2008 | CA2680222A1 Methods of treating ophthalmic diseases |
| 09/18/2008 | CA2680193A1 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof |
| 09/18/2008 | CA2680122A1 Pharmaceutical composition |
| 09/18/2008 | CA2679986A1 Epha3 antibodies for the treatment of solid tumors |
| 09/18/2008 | CA2679720A1 Papillomavirus vaccine compositions |
| 09/18/2008 | CA2679643A1 Procaspase 8-mediated disease targeting |
| 09/18/2008 | CA2679050A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/18/2008 | CA2678732A1 Monoclonal antibodies for treatment of cancer |
| 09/18/2008 | CA2676083A1 Novel multimeric molecules, method for preparing same and use thereof in the preparation of drugs |
| 09/18/2008 | CA2662246A1 Immunoreactive glycoprotein gp19 of ehrlichia canis |
| 09/18/2008 | CA2657898A1 Targeted binding agents directed to pdgfr-alpha and uses thereof |
| 09/18/2008 | CA2652028A1 Secreted campylobacter flagella coregulated proteins as immunogens |
| 09/17/2008 | EP1970449A1 Attenuated salmonella SPI2 mutants as antigen carriers |
| 09/17/2008 | EP1970386A2 Hybrid immunoglobulins |
| 09/17/2008 | EP1970385A2 Tetravalent anti-CD20 and/or anti-CD23 antibodies |
| 09/17/2008 | EP1970384A1 Monoclonal antibodies for treatment of cancer |
| 09/17/2008 | EP1970383A1 Compounds and methods for modulating nonclassical cadherin-mediated functions |
| 09/17/2008 | EP1970074A1 Immune adjuvant |
| 09/17/2008 | EP1970073A1 Enterococcus antigens and vaccines |
| 09/17/2008 | EP1970058A1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 09/17/2008 | EP1969368A2 Potentiation of apoptosis by monoclonal antibodies |
| 09/17/2008 | EP1969011A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (nait) |
| 09/17/2008 | EP1969010A1 Anti-inflammatory dab |
| 09/17/2008 | EP1969009A1 Chimeric antibodies with part new world primate binding regions |
| 09/17/2008 | EP1968998A2 Affinity optimized epha2 agonistic antibodies and methods of use thereof |
| 09/17/2008 | EP1968650A2 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| 09/17/2008 | EP1968637A2 A therapeutic composition comprising an inhibitor of an hsp 90 protein |
| 09/17/2008 | EP1968634A2 IMMUNOGLOBULIN G (IgG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES AND OF POLYREACTIVE IgGs |
| 09/17/2008 | EP1968633A1 Combination therapy using anti-egfr and anti-her2 antibodies |
| 09/17/2008 | EP1968632A1 Improved influenza vaccine |
| 09/17/2008 | EP1968631A2 Vaccine |
| 09/17/2008 | EP1968630A2 Multivalent pcv2 immunogenic compositions and methods of producing such compositions |
| 09/17/2008 | EP1968629A2 Method of eliciting immune response |
| 09/17/2008 | EP1968545A2 Medicament for topical use |
| 09/17/2008 | EP1588162B1 Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
| 09/17/2008 | EP1581794B1 Method of determining risk for prostate cancer recurrence |
| 09/17/2008 | EP1509543B1 Non-immunosuppressive imunogenic or vaccine composition comprising a mutated e7 protein of the hpv-16 virus |
| 09/17/2008 | EP1476582B1 Nucleotide sequence coding for a tolc containing a heterologous amino acid sequence |
| 09/17/2008 | EP1463525B1 Compositions and methods for the diagnosis and treatment of tumor |
| 09/17/2008 | EP1409692B1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 09/17/2008 | EP1379557B1 Use of cd25 binding molecules in steroid-resistant patients |
| 09/17/2008 | EP1305334B1 Urocortin proteins and uses thereof |
| 09/17/2008 | EP1253941B1 Pre-transplant accommodated organs resistant to anti-donor immunity |
| 09/17/2008 | EP1245676B1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof |
| 09/17/2008 | EP1194564B1 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 09/17/2008 | EP1062341B1 Mutant recombinant allergens |
| 09/17/2008 | EP1017714B1 SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) |